| ²é¿´: 1038 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
ice0718ͳæ (ÕýʽдÊÖ)
|
[½»Á÷]
Çó·Ò룬»¯Ñ§ÉúÎïѧ·½ÃæµÄ
|
||
|
In general, an effective G-quadruplex binder possesses a large electron deficient p-aromatic surface, positively charged substituents that can interact with the grooves of the quadruplex, as well as a positively charged center which can reside near the center of the guanine quartet.[16¨C18] Many elegant studies on organic G-quadruplex binders have appeared,[ 19¨C21] but examples involving inorganic complexes are rare. Thus far, inorganic G-quadruplex binders have included copper,[22] manganese,[23] and nickel porphyrins,[24, 25] nickel salens,[18] and ruthenium bis-intercalating complexes[ 26] in their design. Transition-metal complexes are extremely appealing as they introduce a myriad of geometries that are unattainable for carbon, thus expanding the existing organic G-quadruplex binder toolbox. Furthermore, these metal-based binders present an opportunity for modular and facile synthesis of compound libraries, in contrast to their organic counterparts, which often require time-consuming multistep syntheses. Through simple modifications of their coordination environment and the potential to alter their geometries, the incorporation of transition-metals into Gquadruplex binders offers unique possibilities to enhance binding affinity and selectivity for this DNA motif. Platinum-intercalating complexes have been extensively investigated in binding studies with duplex DNA.[27, 28] Previously, binding constants on the order of 106m1 were reported for a relatively small p-surface complex, [Pt(4,4¡¯-diphenyl- 2,2¡¯-bipyridyl)(ethylenediamine)] 2+ with duplex DNA.[29] However, for more p-extended complexes, such as [Pt(dipyridophenazine)( ethylenediamine)] 2+, surprisingly lower binding constants, on the order of 104m1 were reported.[27] These binding constants are markedly lower than those observed for octahedral ruthenium complexes possessing the same intercalating ligand (106¨C107m1),[30] which is not as ¡°p-extended¡± as the squareplanar PtII complexes. This lowered affinity points to a likely size mismatch between the large p-surface of square-planar PtII complexes with extended aromatic ligands and the smaller p-surface of duplex DNA (in addition to other possible factors such as self-aggregation and electronic character).[31] On the other hand, G-quadruplex DNA structures present a planar p-extended system that is greater in size than the duplex DNA base-pairs. We were therefore interested in exploring whether PtII complexes containing extended p-surfaces would be better suited for binding to these structures. We here report the synthesis of the first PtII G-quadruplex selective binding complexes 2 and 3, with readily tunable phenanthroimidazole ligands. UV/Vis, circular dichroism, thermal denaturation, continuous variation analysis, and competitive dialysis experiments show that increasing the size of the p-surface in these complexes indeed leads to an increase in binding affinity and selectivity for G-quadruplexes over duplex DNA structures. This result is supported by molecular modeling studies, which in addition show endstacking of the complexes in an ¡°off-center¡± location above the G-tetrad, and stabilization by hydrogen bonding of the ethylenediamine ligand to the phosphate backbone. Overall, this study shows that combining the square-planar geometry of PtII with extended aromatic ligands can result in a simple method to access effective G-quadruplex selective binders in a few synthetic steps. The modular and facile synthesis of the phenanthroimidazole PtII scaffold is readily amenable to library creation, and further binding optimization for use in telomerase-based antitumor therapy. |
» ²ÂÄãϲ»¶
»¯¹¤¾©Çø271Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
295Çóµ÷¼Á¡£Ò»Ö¾Ô¸±¨¿¼Ö£ÖÝ´óѧ»¯Ñ§¹¤ÒÕѧ˶£¬×Ü·Ö295·Ö
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏ284Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧӢһÊý¶þר˶
ÒѾÓÐ11È˻ظ´
0856»¯¹¤×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
½ËÕʡũ¿ÆÔºÕе÷¼Á1Ãû
ÒѾÓÐ4È˻ظ´
290·Ö²ÄÁϹ¤³Ì085601Çóµ÷¼Á Êý¶þÓ¢Ò»
ÒѾÓÐ3È˻ظ´
0856µ÷¼Á
ÒѾÓÐ7È˻ظ´

xxsst888
ͳæ (СÓÐÃûÆø)
- ·ÒëEPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2042.2
- Ìû×Ó: 295
- ÔÚÏß: 19.2Сʱ
- ³æºÅ: 999183
- ×¢²á: 2010-04-17
- ÐÔ±ð: GG
- רҵ: Ç鱨ѧ
¡ï ¡ï
wypward(½ð±Ò+2):лл²ÎÓ룬ÐÁ¿àÁË£¡ 2010-05-30 18:21:39
ice0718(½ð±Ò+30, ·ÒëEPI+1):лл£¬ÎÒÒѾ·ÒëÍêÁË£¬µ«»¹ÊÇҪллÄã 2010-06-02 19:04:17
wypward(½ð±Ò+2):лл²ÎÓ룬ÐÁ¿àÁË£¡ 2010-05-30 18:21:39
ice0718(½ð±Ò+30, ·ÒëEPI+1):лл£¬ÎÒÒѾ·ÒëÍêÁË£¬µ«»¹ÊÇҪллÄã 2010-06-02 19:04:17
|
ͨ³££¬Ò»¸öÓÐЧµÄG-ËÄÖØ½áºÏ»ù¾ßÓÐÒ»¸ö´óµÄȱµç×ÓµÄp-·¼Ïã»·±íÃæ£¬ÕýµçºÉÈ¡´ú»ù³ýÄÜÔÚËÄÖØÌåµÄ¿ª¿Ú´¦·¢ÉúÈ¡´ú·´Ó¦Í⣬Ҳ´æÔÚÓÚÄñàÑßÊËÄÖØÌåµÄÖÐÐĸ½½ü×öΪÕýµçºÉÖÐÐÄ¡¾16-18¡¿¡££¬¶ÔÓлúÎïµÄG-ËÄÖØ½áºÏ»ùµÄÐí¶à¾«Ï¸Ñо¿¼û¡¾19-21¡¿£¬µ«Éæ¼°µ½ÎÞ»úÎïµÄÀý×ÓÔòÉÙ¼û¡£µ½Ä¿Ç°ÎªÖ¹£¬Ó¦ÓõÄÎÞ»úÎïµÄG-ËÄÖØ½áºÏ»ù°üÀ¨Í¡¾22¡¿£¬ÃÌ¡¾23¡¿£¬ß²ßøÀ໯ºÏÎ24.25¡¿£¬Äøsalens¡¾18¡¿ºÍîɶþ¶È-ÉèÖû¯ºÏÎ26¡¿¡£¹ý¶É½ðÊô»¯ºÏÎïÓÉÓÚÓÐ̼Ô×ÓËù²»¾ßÓеĶ༸ºÎÌå¶øÊܵ½ÃÜÇйØ×¢£¬Ò²À©´óÁËÓлúÎïµÄG-ËÄÖØ½áºÏ»ùµÄÓ¦Ó÷¶Î§¡£»¹ÓУ¬ÕâЩÒÔ½ðÊôΪ»ù´¡µÄ½áºÏ»ùÔÚ»¯ºÏÎïµÄºÏ³É·½ÃæÕ¹ÏÖ³ö¶àÄ£ÐÍÐÔºÍÁé»îÐÔ£¬¶øÓë´ËÏà¶ÔÓ¦µÄÓлú»¯ºÏÎï³£³£ÐèÒª·´Ó¦Ê±¼ä¶øÇÒ¾Àú¶à¸ö·´Ó¦²½Öè¡£¹ý¶É½ðÊôͨ¹ý¼òµ¥µÄµ÷ÕûËüÃǵķ´Ó¦»·¾³ºÍDZÄÜÈ¥¸Ä±äËüÃǵļ¸ºÎ¹¹ÐÍ£¬¿É½áºÏµ½G-ËÄÖØ½áºÏ»ùµÄ¹ý³ÌÌṩÁ˶ÀÌØµÄ»ú»á¼ÓÇ¿DNAÁ´µÄÑ¡ÔñÐÔºÍÇ׺ÍÐÔ¡£ÒÔǰ¶Ô²¬-ÉèÖû¯ºÏÎïÓëË«Á´DNA¡¾27.28¡¿µÄ½áºÏÐÔ½øÐÐÁ˹㷺µÄÑо¿£¬¶ÔÏà¶ÔСµÄp-±íÃæÂçºÏÎï[Pt(4,4¡¯-diphenyl-2,2¡¯-bipyridyl)(ethylenediamine)] 2+ with duplex DNA.[29£¬ÔÚ106 1¼¶ÉϵĽáºÏ³£Êý½øÐÐÁ˼Ǽ¡£È»¶ø£¬¶Ô¸ü¶àµÄp-À©³äʽ»¯ºÏÎïÈç[Pt(dipyridophenazine)( ethylenediamine)] 2+£¬ÔÚ¼¶Êý104m 1ÉϵĽáºÏ³£ÊýÊÇÁîÈ˾ªÆæµÄµÍ¡£¡¾27¡¿ÕâЩ½áºÏ³£ÊýÃ÷ÏÔµÍÓÚÄÇЩӵÓÐÏàͬ²åλ»ùµÄ°ËÃæÌåîÉÂçºÏÎï( 106¨C107m 1),[30]µÄ½áºÏ³£Êý£¬ËüÃDz»ÏñÆ½ÃæËÄÃæÌåµÄPtIIÂçºÏÎïÓС°p-À©³ä¡±¡£Õâ¸öµÍµÄÇ׺ÍÁ¦Ö¸³öÔÚ´øÓÐÀ©³ä·¼Ïã»·ÅäºÏ»ùµÄÆ½ÃæËÄ·½PtIIÂçºÏÎïµÄ´óp-±íÃæºÍË«½ÊÁ´DNAµÄСµÄp-±íÃæÖ®¼äËÆºõ´æÔÚÃæ»ý´îÅä´íÎó¡¾31¡¿£¨³ýÁËÆäËü¿ÉÄÜÐÔÒòËØÈç×ÔÎÒ¾Û¼¯ºÍµç×ÓµÄÌØÐԵȣ©¡£ÁíÒ»·½Ã棬G-ËÄÖØDNA½á¹¹Õ¹ÏÖÒ»¸öÔÚÃæ»ýÉÏ´óÓÚË«½ÊÁ´DNA-¼îµÄÆ½Ãæp-À©³äϵͳ¡£Òò´Ë£¬ÕâÒ»ÏÖÏóÒýÆðÎÒÃÇÑо¿ÊÇ·ñº¬ÓÐÀ©³äµÄp-±íÃæµÄ PtIIÂçºÏÎï»á¸ü¼ÓÊʺÏÁ¬½Óµ½ÕâЩ½á¹¹ÖеÄÐËȤ¡£ÕâÀÎÒÃǼǼÁËPtII G-ËÄÖØµÄÑ¡ÔñÐÔÁ¬½ÓÂçºÏÎï2ºÍ3µÄºÏ³É£¬Í¨¹ý¿Éµ÷µÄphenanthroimidazole½áºÏ»ù£¬. UV/Vis,£¬Ñ»··ÖÉ«ÐÔ£¬ÈȱäÐÔ£¬Á¬Ðø±äÌå·ÖÎöºÍ׼ȷµÄ·ÖÀëʵÑéµÈ±íÃ÷ÔÚÕâЩÂçºÏÎïÖÐÔö¼Óp-±í̾̾»ýȷʵÄÜʹG-ËÄÖØ¶ÔË«Á´DNA½á¹¹Ôö¼ÓÇ׺ÍÁ¦ºÍÑ¡ÔñÐÔ¡£Õâ¸ö½á¹ûÊܵ½·Ö×ÓÄ£ÐÍÑо¿µÄÖ§³Ö¡£¸ÃÏîÑо¿±íÃ÷ÂçºÏÎïÔÚG-ËÄÖØÖ®ÉϵķÇÖÐÐÄλÖöѻý£¬ÓÉÒÒ¶þ°·½áºÏ»ùµÄÇâ½áºÏµ½Á×ËáÑÎÖ÷Á´É϶øÏÔÎȶ¨ÐÔ¡£×ÜÖ®£¬¸ÃÏîÑо¿±íÃ÷PtIIµÄÆ½ÃæËÄ·½Ì弸ºÎ½á¹¹ÓëÀ©³äµÄ·¼Ïã»·½áºÏ»ùµÄ½áºÏÄܲúÉúÒ»¸ö¼òµ¥µÄ·½·¨ÒÔÖÁÔÚһЩºÏ³É·´Ó¦²½ÖèÖÐȥʹÓÃG-ËÄÖØµÄÓÐЧѡÔñ½áºÏ»ù¡££¬the phenanthroimidazole PtII½á¹¹µÄºÏ³É±ê×¼ÐÔºÍÁé»îÐÔ»¹ÐèÍêÉÆ¡£ÔÚ¶ËÁ£Ã¸-¼î¿¹Ö×ÁöÖÎÁÆÖл¹Òª½øÒ»²½¶Ô½áºÏ»ù½øÐÐÓÅ»¯¡£ ÄÄÓн»ÒÆÃñ£¨¼ÓÄôó£¬Ó¢¹ú£©µÄÅóÓÑÍøÕ¾ |

2Â¥2010-05-29 16:40:38













»Ø¸´´ËÂ¥